Skip to main content

David Kratochvil

David Kratochvil has been appointed CFO and Treasurer of VolitionRx, effective Aug. 17. He will lead the firm's financial strategy as it prepares for the launch of the NuQ tests in the US and elsewhere. Ktratochvil replaces Mike O'Connell. 

Kratochvil joins VolitionRx from Euro Pacific Capital where he was managing director in the corporate finance department. Before that, he was at Omega Advisors and a director at Merrill Lynch Asset Management. He also founded his own advisory firm Vista Capital Advisors. 

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.